|
|
|
Course Title |
|
In Utero Drug Exposure and Neonatal Abstinence Syndrome |
|
|
Faculty |
|
Eric Reynolds, MD, MPH
Kosair Children’s Hospital Neonatal Specialists
Dr. Reynolds completed undergraduate and medical school at the University of Louisville. He was a Pediatric Resident at the Northeast Ohio Universities College of Medicine in Youngstown, OH. He began his Neonatology Fellowship at the University of Maryland and completed it at the University of Kentucky. Upon graduation he joined the faculty at the University of Kentucky. He completed a Master of Public Health degree in Health Services Management in the Spring of 2008. Dr. Reynolds was awarded an NIH grant to study the development of infant feeding and is an author of several published manuscripts on topics affecting neonatal care. In September of 2011, he joined Kosair Children’s Hospital Neonatal Specialists in Louisville, Ky. He remains an active participant in the Southern Society for Pediatric Research. He is President of the Kentucky Perinatal Association.
|
|
|
Program Overview |
|
This lecture series identifies NAS and the epidemiology of the disease. Presentation of the newborn with NAS is described. Various treatments are described. The future of NAS management is also mentioned.
|
|
|
Target Audience |
|
This activity has been designed to meet the educational needs of Physicians and Nurses. |
|
|
Learning Objectives |
|
After participating in this program, the medical professional should be able to:
• Discuss the scope of the problem of in utero drug exposure and neonatal abstinence syndrome
• Discuss the presentation, signs and symptoms of infants affected by neonatal abstinence syndrome
• Discuss some common treatments for NAS
• Discuss the current state of public health responses to NAS
|
|